GSK | ||
|---|---|---|
OUTLOOK RATING 1..100 | 75 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 10 Undervalued | |
PROFIT vs RISK RATING 1..100 | 40 | |
SMR RATING 1..100 | 40 | |
PRICE GROWTH RATING 1..100 | 41 | |
P/E GROWTH RATING 1..100 | 88 | |
SEASONALITY SCORE 1..100 | 65 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| FICS | GSK | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 83% | 2 days ago 48% |
| Stochastic ODDS (%) | 2 days ago 68% | 2 days ago 42% |
| Momentum ODDS (%) | 2 days ago 78% | 2 days ago 70% |
| MACD ODDS (%) | 2 days ago 77% | 2 days ago 58% |
| TrendWeek ODDS (%) | 2 days ago 80% | 2 days ago 62% |
| TrendMonth ODDS (%) | 2 days ago 76% | 2 days ago 56% |
| Advances ODDS (%) | 2 days ago 81% | 3 days ago 60% |
| Declines ODDS (%) | 10 days ago 81% | 29 days ago 51% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 49% |
| Aroon ODDS (%) | 2 days ago 73% | 2 days ago 48% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BRKU | 25.45 | 0.51 | +2.04% |
| Direxion Daily BRKB Bull 2X Shares | |||
| AVGV | 71.71 | 0.35 | +0.50% |
| Avantis All Equity Markets Value ETF | |||
| VMO | 9.75 | N/A | N/A |
| Invesco Municipal Opportunity Trust | |||
| GEMD | 42.72 | -0.02 | -0.04% |
| Goldman Sachs Access Emrg Mkts USD BdETF | |||
| VTWO | 98.48 | -0.26 | -0.26% |
| Vanguard Russell 2000 ETF | |||
A.I.dvisor indicates that over the last year, FICS has been closely correlated with SLF. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if FICS jumps, then SLF could also see price increases.
| Ticker / NAME | Correlation To FICS | 1D Price Change % | ||
|---|---|---|---|---|
| FICS | 100% | +0.06% | ||
| SLF - FICS | 67% Closely correlated | +2.02% | ||
| BMO - FICS | 64% Loosely correlated | +0.85% | ||
| TD - FICS | 62% Loosely correlated | +1.40% | ||
| SAN - FICS | 59% Loosely correlated | +2.41% | ||
| GSK - FICS | 56% Loosely correlated | -0.70% | ||
More | ||||
A.I.dvisor indicates that over the last year, GSK has been closely correlated with NVS. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if GSK jumps, then NVS could also see price increases.